Author:
Buti Maria,Tsai Naoky,Petersen Joerg,Flisiak Robert,Gurel Selim,Krastev Zahary,Aguilar Schall Raul,Flaherty John F.,Martins Eduardo B.,Charuworn Prista,Kitrinos Kathryn M.,Mani Subramanian G.,Gane Edward,Marcellin Patrick
Publisher
Springer Science and Business Media LLC
Subject
Gastroenterology,Physiology
Reference22 articles.
1. Lok AS. Chronic hepatitis B. N Engl J Med. 2002;346:1682–1683.
2. Chen CJ, Yang HI, Su J, et al. Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level. JAMA. 2006;295:65–73.
3. Iloeje UH, Yang HI, Su J, et al. Predicting cirrhosis risk based on the level of circulating hepatitis B viral load. Gastroenterology. 2006;130:678–686.
4. Di Marco V, Di Stefano R, Ferraro D, et al. HBV-DNA suppression and disease course in HBV cirrhosis patients on long-term lamivudine therapy. Antivir Ther.. 2005;10:431–439.
5. De Clercq E, Ferir G, Kaptein S, Neyts J. Antiviral treatment of chronic hepatitis B virus (HBV) infections. Viruses. 2010;2:1279–1305.
Cited by
253 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献